Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Conference News EuroPCR 2016

Sex Disparities in MI Care Are Narrowing, but There’s Still a Long Way to Go

Caitlin E. Cox

May 25, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

Innovative Initiatives in Radiation Safety Lower Patient, Operator Dose in the Cath Lab

Yael L. Maxwell

May 20, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

Presentation EuroPCR 2016

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Presenter: Josep Rod?s-Cabau

May 19, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Shelley Wood

May 18, 2016

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

News Conference News EuroPCR 2016

WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients

Caitlin E. Cox

May 17, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Conference News EuroPCR 2016

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Yael L. Maxwell

May 17, 2016

News Conference News EuroPCR 2016

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Yael L. Maxwell

May 17, 2016

Presentation EuroPCR 2015

Two-year results in the Nordic-Baltic bifurcation study IV

Presenter: Indulis Kumsars

May 21, 2015

News Conference News EuroPCR 2015

PERFECT-2: Angioplasty Can Effectively Treat Erectile Dysfunction But Restenosis an Issue

Caitlin E. Cox

May 21, 2015

News Conference News EuroPCR 2015

CT-Derived FFR Alters Angiography-Based Management Plans for Stable Angina

Yael L. Maxwell

May 20, 2015

News Conference News EuroPCR 2015

PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI

Caitlin E. Cox

May 19, 2015

Presentation EuroPCR 2015

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Presenter: Ota Hlinomaz

May 19, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Conference News EuroPCR 2015

DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk

Yael L. Maxwell

May 19, 2015

News Conference News EuroPCR 2014

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Yael L. Maxwell

May 21, 2014

Advertisement

Sex Disparities in MI Care Are Narrowing, but There’s Still a Long Way to Go

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Innovative Initiatives in Radiation Safety Lower Patient, Operator Dose in the Cath Lab

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Two-year results in the Nordic-Baltic bifurcation study IV

PERFECT-2: Angioplasty Can Effectively Treat Erectile Dysfunction But Restenosis an Issue

CT-Derived FFR Alters Angiography-Based Management Plans for Stable Angina

PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Evolving DES Technology May Benefit Diabetic Patients

DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content